Company Filing History:
Years Active: 2025
Title: Rina Wassermann: Innovator in Cancer Treatment
Introduction
Rina Wassermann is a prominent inventor based in Ramat Gan, Israel. She has made significant contributions to the field of cancer treatment through her innovative research and development of mRNA translation modulators. With a total of 2 patents, her work is paving the way for new therapeutic approaches in oncology.
Latest Patents
Wassermann's latest patents include groundbreaking inventions related to c-MYC mRNA translation modulators. The first patent focuses on novel c-MYC mRNA translation modulators, compositions, and methods of preparation, specifically aimed at treating cancer. The second patent also addresses c-Myc mRNA translation modulators and their applications in cancer treatment, showcasing her commitment to advancing medical science.
Career Highlights
Rina Wassermann is currently associated with Anima Biotech Inc., where she continues to push the boundaries of cancer research. Her work has garnered attention for its potential to revolutionize treatment options for patients suffering from various forms of cancer.
Collaborations
Throughout her career, Wassermann has collaborated with notable professionals in her field, including David William Sheppard and Jason Paul Tierney. These partnerships have enhanced her research and contributed to the development of her innovative patents.
Conclusion
Rina Wassermann's contributions to cancer treatment through her innovative patents highlight her role as a leading inventor in the field. Her work not only reflects her dedication to scientific advancement but also offers hope for improved therapeutic options for cancer patients.